Covid-19 led to a surge in the use of telehealth across the U.S. But what’s likely to happen next? Will we see long-term impact on healthcare business models, health outcomes, and consumer expectations about healthcare convenience and access? To understand how industry leaders are thinking about telehealth in light of…
Well before Covid-19 came on the scene, telehealth had earned its stripes as a cost-effective care delivery and population health platform. Despite numerous benefits, telehealth’s potential was marginalized by the lobbying efforts of hospitals, medical associations, and specialists seeking to defend their turf and the lucrative nature of current fee-for-service…
There are myriad reasons why providers have yet to adopt the risk-based arrangements that add value to care delivery, 2 of the latest claims being a lack of adequate data and quality-measure incentives. However, statements like these largely reflect resistance. Most have more data than they realize, and they have…
Walgreens made headlines recently with the news that it was getting out of the walk-in clinic business. The news sparked interesting reactions across the industry. Some pundits pointed to managerial missteps; healthcare delivery insiders breathed a sigh of relief, while others shot a knowing smile that said, “I told you…
